Active ingredient: Long-R3 IGF-1 Alternate names: Long-R3 IGF-1, IGF, Long arginine 3-IGF-1 Long arginine 3-IGF-1, commonly referred to as IGF-1 LR3 or LR3-IGF-1, is a synthetic protein and an elongated analogue of human insulin-like growth factor 1 (IGF-1).Half-life: 20-30 hours IGF Effects: The latest formulation is Long-R3 IGF-1, which has been chemically modified to have amino acid alterations that reduce its binding to proteins in the human body, granting it a longer half-life of approximately 20-30 hours. Igtropin (Long-R3 IGF-1) enhances amino acid transport into cells, promotes glucose transport, stimulates protein synthesis, decreases protein breakdown, and increases RNA synthesis. When active, Igtropin (Long-R3 IGF-1) interacts differently across various tissues, stimulating muscle cells and proteins. It significantly contributes to muscle enhancement. Igtropin (Long-R3 IGF-1) encourages both the proliferation and differentiation of stem cells in an autocrine-paracrine manner, albeit with a stronger emphasis on differentiation. Locally injected, it promotes satellite cell activity, muscle DNA, increases muscle protein levels, muscle mass, and muscle cross-sectional area. The significance of Igtropin (Long-R3 IGF-1) lies in its ability to stimulate muscle growth regardless of excess food intake, and it is particularly effective when combined with physical exercise. It also boosts protein production alongside amino acid utilization for energy, facilitating fat mobilization for energy within muscle tissue. In lean muscle, Igtropin (Long-R3 IGF-1) inhibits insulin from transporting glucose into cells, causing them to rely on fat for energy instead. This drug mimics insulin effects in the body, enhancing muscular sensitivity to insulin. Therefore, individuals who are on insulin therapy may reduce their dosage significantly while achieving similar effects, and Igtropin (Long-R3 IGF-1) can help prevent weight gain associated with insulin use. One of the most intriguing and potent effects of this substance is its capability to induce hyperplasia, which is the physical increase in the number of muscle cells. In contrast, hypertrophy refers to the growth of existing muscle cells that occurs with weightlifting. After puberty, individuals typically have a set number of muscle cells, and can only increase their size through exercise. However, using this substance allows for a potential increase in muscle cell count, which can be developed into larger, stronger cells through training. Thus, this medication may have the potential to modify genetic predispositions regarding muscle density and size. Possible Side Effects: joint pain, muscle soreness, headaches, nausea, hypoglycemia.
Instructions for Use:
To achieve optimal results, IGF-1 Long R3 should be used at a dosage of 100-140mcg per day. A typical treatment cycle with IGF-3 Long R3 lasts 4-6 weeks and involves splitting the daily dose into two injections post-exercise. After completing a cycle, a break equal to the treatment duration is recommended to reduce the risk of antibody production and prevent the body from adapting to IGF-1 Long R3.
